Topic
Risk Stratification
Fillmore has focused on improving risk stratification for cancer patients by developing and validating predictive models for cardiovascular disease and cancer-associated thromboembolism. He has integrated diverse data sources, including electronic health records, plasma protein panels, circulating tumor DNA, and machine learning architectures, to outperform traditional static risk scores. Additionally, he has identified clinical and molecular biomarkers, such as frailty indices and lymphocyte counts, to better predict survival and treatment outcomes in patients with hematologic malignancies and lung cancer.
Publications (16)
2026
2026
2025
2025
2025
2025
2025
2025
2025
2024
2023
2023
2023
2023
2023
2022